Shanmuga Hospital Limited · BSE:SHANMUGA

Shanmuga Hospital — Investor Presentation (November 2025)

38 slides from Shanmuga Hospital's investor presentation, Nov 28, 2025

  1. Slide 1: Shanmuga Hospital Limited Investor Presentation Filing Letter

    SHANMUGA HOSPITAL LIMITED Formerly known as Shanmuga Hospital Private Limited Reg. Off: 51/24, Saradha College Road, Salem—636 007. CIN: L85110TZ2020PLC033974 | GSTIN: 33ABDCS8326A1ZP Tele: 0427-2706674 |E-mail: secretarial@shanmugahospital.com Website: www.shanmugahospital.com ISIN: INE0TD301017 |

  2. Slide 2: Investor Presentation H1 FY26

    SHANMUGA HOSPITAL LIMITED Investor Presentation H1 FY 26

  3. Slide 3: Safe Harbor Statement

    Safe Harbor Statement This presentation and the accompanying slides (The Presentation), which have been prepared by Shanmuga Hospital Limited (The Company) solely for informational purposes, do not constitute any offer, recommendation, or invitation to purchase or subscribe for any securities, and s

  4. Slide 4: Company Overview

    “ha 4 OD iii ji Texas fl) i LS a Sa — / ee te it i = ee

  5. Slide 5: Shanmuga Hospital

    Delivering Quality & Affordable Healthcare for Over Four Decades Shanmuga Hospital Limited, established in 1981 by Dr. Panneerselvam Shanmuga 1 Palaniappan Shanmugam, is a Multi Specialty Hospital based in Salem, Tamil Nadu. Hospital The hospital provides advanced medical and surgical care through s

  6. Slide 6: Journey: From Inception to Public Listing

    Journey: From Inception to Public Listing 2025 Successfully 2024 listedon the BSE SME, Converted to a marking a key PublicLimited milestone in the Company as company’s 2023 Shanmuga growth journey. Obtained NABL Hospital Limited. Accreditation for 2022 Shanmuga Diagnostics. Obtained NABH 2020 Accred

  7. Slide 7: Shanmuga Hospital at a Glance

    Shanmuga Hospital at a Glance 25+ Medical 50+ Equipment Units Robotic Surgeries 150+ Bed Capacity 40+ Years of Trusted H1 FY26 Health care Service ROE: 4.94% ROCE: 5.87% 70+ H1 FY26 Experienced Revenue: 24.72 Cr Doctors EBITDA: 4.6 Cr PAT: 2.01Cr NABH & NABL Accreditations 6 Investor Presentation H1

  8. Slide 8: Delivering Decades of Care

    Delivering Decades of Care 30,000+ 6,000+ 60,000+ Endoscopies CancerSurgeries Chemotherapy Sessions 10,000+ LaparoscopicSurgeries 1,00,000+ 20,000+ 3,00,000+ Surgeries Performed RadiotherapyTreatments Radiology & Test 7 Investor Presentation H1 FY26

  9. Slide 9: Recognised for Quality and Excellence

    Recognised for Quality and Excellence NABH Accreditation Nursing Excellence NABL Accreditation Shanmuga Hospitalhas received full Shanmuga Hospitalhas received Shanmuga Hospital Laboratory is AccreditationCertificationfrom NursingExcellenceCertification from accreditedbythe National National Accredi

  10. Slide 10: Visionaries Behind the Mission

    Visionaries Behind the Mission Dr. Panneerselvam Palaniappan Dr. Prabu Sankar Panneerselvam Mrs. Jayalakshmi Panneerselvam Dr. Dhandapani Priyadharshni Shanmugam Promoter & Executive Directorcum Promoter& ExecutiveDirector Promoter &Non-ExecutiveDirector Promoter & Managing Director Chief Executive

  11. Slide 11: Recognised by The Times of India

    RECOGNISED BY THE TIMES OF INDIA

  12. Slide 12: Business Overview

    BUSINESS OVERVIEW

  13. Slide 13: Integrated Healthcare Infrastructure Across Units

    Integrated Healthcare Infrastructure Across Units Shanmuga Hospital Shanmuga Diagnostics Salem, Tamil Nadu Salem, Tamil Nadu The centrally located flagship facility in Serving as a specialized pathology laboratory, Salem spans two blocks and three floors, catering to both OPD and IPD patients. offer

  14. Slide 14: Expert Care Across Specialities

    Expert Care Across Specialities Surgical Oncology General Surgery Orthopaedics Gastroenterology Paediatrics & Cardiology General Medicine Neurology Neonatology Endocrinology & Diabetes Plastic Surgery Respiratory Medicine 12 Investor Presentation H1 FY26

  15. Slide 15: Other Allied Healthcare Services

    Other Allied Healthcare Services Cardiothoracic Surgery Obstetrics& Neurosurgery Services Urology Services Nephrology Services Services Gynaecology Services Anaesthesiology Dermatology and Emergency Medicine Radiodiagnosis Otorhinolaryngology including Critical Care Venereology Services Services Ser

  16. Slide 16: Advanced Medical Technology at a Glance

    Advanced Medical Technology at a Glance Robotic Surgery Da Vinci Xi System 2 LINAC Machines (Radiotherapy) Cath Lab with IVUS (Intra Vascular Ultrasound) The hospital’s catheterization laboratory is Shanmuga Hospital uses the Da Vinci Xi The hospital is equipped with two Linear equipped with Intra V

  17. Slide 17: Advanced Medical Technology at a Glance

    Advanced Medical Technology at a Glance Plasma Sterilizer (Infection Control) Fully Automated Biochemistry Lab (2 Units) CT Scan Shanmuga Hospital is equipped with Shanmuga Hospital employs plasma The hospital operates two fully automated state-of-the-art CT scanning technology, sterilization techno

  18. Slide 18: Key Operational Performance & Patient Volumes

    Key Operational Performance & Patient Volumes Operational Scale Total Bed Capacity: 151 Inpatients: 2141 Operational Beds: 120 Average Occupancy: 47.5 Patient Volume H1 FY26 Robotic Outpatients: Surgeries Performed: Average Revenue Per Bed: 23131 40 robotic surgeries ₹24,327 (Approx.) AverageLengtho

  19. Slide 19: DNB Specialties: Direct Impact on Patient Care & Hospital Value

    DNB Specialties: Direct Impact on Patient Care & Hospital Value DNB(DiplomateofNationalBoard)isapostgraduatemedicalprograminIndiathattrainsdoctorsinspecialtiesthrough hospital- based learning, helping hospitals improve clinical capacity and address specialist staffing needs. DNB Emergency Medicine D

  20. Slide 20: Comprehensive Healthcare Setup

    Comprehensive Healthcare Setup 18 Investor Presentation H1 FY26

  21. Slide 21: Service Wise Revenue Break Up

    Service Wise Revenue Break Up H1 FY26 H1 FY25 FY25 1,333.90 720.98 604.37 3,451.42 1857.7 1,741.20 Hospital Sales & Services Hospital Medicinal Sales (₹ in Lakhs) Particulars H1 FY26 H1 FY25 FY25 Hospital Sales & Services 1857.7 1,741.20 3,451.42 Hospital Medicinal Sales 604.37 720.98 1,333.90 Total

  22. Slide 22: Industry Overview

    INDUSTRY OVERVIEW

  23. Slide 23: India's Hospital Market Set to Nearly Double by 2032

    India’s Hospital Market Set to Nearly Double by 2032 Overall Healthcare Healthcare Hospital Market Size Projected Hospital Forecasted CAGR Market (FY25) Employment (FY24) in 2024 Market Size by 2032 (2024 - 2032) Estimated at 7.5MillionPeople US$98.98Billion US$193.59Billion 8.0% US$ 638 Billion Emp

  24. Slide 24: India's Healthcare Sector: Investment Momentum & Policy Support

    India’s Healthcare Sector: Investment Momentum & Policy Support Investment Landscape Policy & Government Support Private Equity & VCInvestments: Healthcare Budget(FY26): • Over US$ 1 Billioninfirstfive months ofFY24 • ₹99,858 Crore (US$ 11.50 Billion) FDI (FY 2000 – FY 2024): PMJAY Outlay: • Drugs &

  25. Slide 25: Financial Overview

    FINANCIAL OVERVIEW

  26. Slide 26: Financial Highlights

    Financial Highlights EBITDA PAT Revenue 6,000 .0 0 897.00 3 0. 00 896.00 895.00 894.00 893.00 892.00 891.00 890.00 889.00 888.00 887.00 886.00 885.00 884.00 883.00 882.00 5000 1000 1000 881.00 880.00 879.00 878.00 877.00 876.00 875.00 874.00 873.00 872.00 871.00 870.00 869.00 868.00 867.00 866.00 1

  27. Slide 27: Profit & Loss Statement

    Profit & Loss Statement In ₹ Lakhs Particulars H1 FY26 H1 FY25 FY25 Revenues 2,462.07 2,462.18 4,785.33 Other Income 9.94 20.63 23.35 Total Income 2,472.01 2,482.81 4,808.67 Cost of Consumption 965.85 813.05 1,772.74 Employee Costs 366.76 304.54 559.25 Finance Costs 22.86 33.96 62.67 Depreciation 17

  28. Slide 28: Balance Sheet

    Balance Sheet In ₹ Lakhs Equities&Liabilities H1 FY26 FY25 FY24 H1 FY26 FY25 FY24 Assets Equity 1,361.30 1,361.30 979.50 Non Current Assets Reserves 2,809.63 2,608.51 733.85 Fixed Assets 3,941.35 2,242.71 2,018.30 Net Worth 4,170.93 3,969.81 1,713.35 Non Current Investments 2.74 2.74 2.48 Non Curren

  29. Slide 29: Cash Flow Statement

    Cash Flow Statement In ₹ Lakhs Particulars H1 FY26 FY25 FY24 Cash from Operation 2,012.58 (1,263.71) 957.91 Cash from Investments (1,971.11) (448.30) (1,159.31) Cash from Financing (41.76) 1,639.45 89.85 Net Cash Flow (0.29) (72.55) (111.55) 27 Investor Presentation H1 FY26

  30. Slide 30: Key Ratios & Margins

    Key Ratios & Margins ROE ROCE EBITDA PAT 20 18.73% 18.68% 15 13.05% 12% 10 10% 8% 5.87% 5 4.94% H1 FY25 H1 FY26 All Margins In % 28 Investor Presentation - H1 FY26

  31. Slide 31: Key Ratios

    Key Ratios Debt to Equity Current Ratio 5 0.6 4 3.35 3 0.4 0.32 2 1.60 0.2 1.18 1 0.09 0.10 0.0 0 H1 FY26 H1 FY25 FY 25 H1 FY26 H1 FY25 FY 25 All Ratios In Times 29 Investor Presentation H1 FY26

  32. Slide 32: Key Ratios

    Key Ratios 6 Earnings Per Share 40 Net Asset Value Per Share 5 30.64 29.16 30 4.03 4 19.94 3 20 2.44 2 1.48 10 1 0 0 H1 FY26 H1 FY25 FY25 H1 FY26 H1 FY25 FY25 Amount In ₹ 30 Investor Presentation H1 FY26

  33. Slide 33: The Path Ahead

    THE PATH AHEAD

  34. Slide 34: Competitive Strengths

    Competitive Strengths Strong Oncology Presence Promoters with 40+ Years of Experience Shanmuga Hospitalofferscomprehensive cancer Thepromoters bring over fourdecadesof healthcare care provider in the region,supportedbya dedicated experience, integratinga legacy of patient centric team of oncologists

  35. Slide 35: Strategic Healthcare Initiatives For Business Scaling

    Strategic Healthcare Initiatives For Business Scaling Increase in Launch of Nephro InpatientCapacity Care Center The company plans to expand its infrastructure by A dedicated center for adding 50 additional kidney care will be inpatient beds, improving established to provide its ability to accommoda

  36. Slide 36: Investment Rationale

    Investment Rationale Legacy Over 40yearsoftrusted healthcaredeliveryinSalem with multi-generational patient relationships. Specialty Focus Strong presence in oncology and other critical specialties, including plans for renal transplant and robotic surgery Strategic Accreditations NABH & NABL certifi

  37. Slide 37: Stock Data

    Stock Data Stock Information Share Holding Pattern As on 25-11-2025 As on Sptember-2025 Share Price (₹) 49.5 Public 27.9% Market Capitalization (₹ Cr) 67.38 Total Number of Shares 1,36,13,000 Face Value (₹) 10.00 Promoter 72.1% 52 Week High / Low (₹) 54.00 / 31.00 35 Investor Presentation H1 FY26

  38. Slide 38: Thank You

    Thank You Shanmuga Hospital Limited 51/24,Saradha CollegeRoad,Salem-636007, Tamil Nadu, India. Tel No: 0427-2706674 Email: secretarial@shanmugahospital.com | Website: www.shanmugahospital.com

Shanmuga Hospital — Investor Presentation (November 2025) on 6ix